XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.1

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Schedule of allocation of total stock-based compensation expense

​

​	​	​	​	​	​
​	Three Months Ended
​	March 31,
(In thousands)	2023			2022
Cost of revenue	$	103	​	$	102
Sales and marketing expenses	​	752	​	​	1,027
Research and development expenses	​	49	​	​	83
Reimbursement, general and administrative expenses	​	1,119	​	​	1,016
Total stock-based compensation expense	$	2,023	​	$	2,228

​

Schedule of stock option activity

​

​	​	​	​	​	​	​	​	​	​	​
​		​	​	Weighted-		​	Weighted-	​	​	​
​	​	​	​	Average		​	Average	​	Aggregate
​	​	Options	​	Exercise Price		​	Remaining	​	Intrinsic
(In thousands except options and per share data)	​	Outstanding	​	Per Share (1)		​	Contractual Life	​	Value (2)
Balance at December 31, 2022	​	615,307	​	$	43.25	​	4.7 years	​	$	164
Granted	​	—	​	$	—	​	​	​	​	​
Exercised	​	(316)	​	$	1.11	​	​	​	$	4
Forfeited	​	(12,065)	​	$	44.78	​	​	​	​	​
Cancelled/Expired	​	(16,714)	​	$	48.81	​	​	​	​	​
Balance at March 31, 2023	​	586,212	​	$	43.09	​	4.4 years	​	$	358
​	​	​	​	​	​	​	​	​	​	​
Options exercisable at March 31, 2023	​	479,622	​	$	44.60	​	4.2 years	​	$	162

​

(1) The exercise price of each option granted during the period shown was equal to the market price of the underlying stock on the date of grant.

(2) The aggregate intrinsic value of options exercised represents the difference between the exercise price of the option and the closing stock price of our common stock on the date of exercise. The aggregate intrinsic value of options outstanding represents the difference between the exercise price of the option and the closing stock price of our common stock on the last trading day of the period.

Time-Based Restricted Stock Units

Schedule of stock-settled restricted stock unit activity

​

​	​	​	​	​	​	​	​	​
​	​	​	​	Weighted-		​	​	​
​		​		Average Grant			Aggregate
​	​	Units	​	Date Fair Value		​	Intrinsic
(In thousands except unit and per unit data)	​	Outstanding	​	Per Unit		​	Value (1)
Balance at December 31, 2022	​	590,542	​	$	19.42	​	$	6,779
Granted	​	269,461	​	$	14.35	​	​	​
Vested	​	(102,651)	​	$	26.44	​	​	​
Cancelled	​	(18,613)	​	$	25.14	​	​	​
Balance at March 31, 2023	​	738,739	​	$	16.45	​	$	12,130

​

(1) The aggregate intrinsic value of restricted stock units outstanding was based on our closing stock price on the last trading day of the period.

Performance-based stock-settled restricted stock units

Schedule of stock-settled restricted stock unit activity

​

​	​	​	​	​	​	​	​	​
​	​	​	​	Weighted-		​	​	​
​		​		Average Grant			Aggregate
​	​	PSUs	​	Date Fair Value		​	Intrinsic
(In thousands except unit and per unit data)	​	Outstanding	​	Per Unit		​	Value (1)
Balance at December 31, 2022	​	155,618	​	$	25.05	​	$	1,786
Granted	​	106,183	​	$	14.35	​	​	​
Vested	​	(9,915)	​	$	51.89	​	​	​
Cancelled	​	(7,762)	​	$	26.33	​	​	​
Balance at March 31, 2023	​	244,124	​	$	19.27	​	$	4,009

​

(1) The aggregate intrinsic value of PSUs outstanding was based on our closing stock price on the last trading day of the period.

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_AwardTypeAxis=tcmd_TimeBasedRestrictedStockUnitsRsusMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_AwardTypeAxis=tcmd_PerformanceBasedStockSettledRestrictedStockUnitsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: